Biotech News

The latest biotechnology news and insights Sign up to our newsletter

Newleos Therapeutics Appoints Timothy Noyes as President and CEO

Aarvik Therapeutics Welcomes Laurus Labs as Strategic Investor

Leyden Labs Raises €30M from EIC Fund and Invest-NL for Respiratory Virus Pipeline

Pfizer to Acquire Metsera in $4.9 Billion Obesity Drug Deal

Charles River Explores Crowdfunding Partnership to Support Early-Stage Biotech Firms

Uniquity Bio Appoints Will Kane as CEO

Merck to Acquire Verona Pharma in $10 Billion Deal

Circio Expands Stockholm Lab to Advance Circular RNA Drug Development

Orano Med Doubles Clinical Supply Capacity at Plano Facility

64x Bio Launches AAV Apex Suite to Tackle Gene Therapy Manufacturing Bottlenecks

Debiopharm Partners with Alkyon to Advance Targeted Radioligand Therapies

Medicovestor Signs Strategic Partnership with Sanyou Biopharmaceuticals to Advance Chemoimmunotherapy ADCs

Scinai Immunotherapeutics Secures Golden Power Clearance in Move to Acquire Pincell

bitBiome Expands into Commercial Manufacturing Through Strategic CMO Partnership

Leyden Labs Secures €20M from EIB to Advance Nasal Spray Against Influenza

Taiho Pharmaceutical Expands ADC Capabilities with Araris Biotech Acquisition

C2N Diagnostics Secures $10M Investment from Samsung for Brain Health Innovation

Jazz Pharmaceuticals to Acquire Chimerix for $935M in Rare Oncology Expansion

Callio Therapeutics Launches with $187M to Develop Next-Gen ADC Cancer Therapies

Eikon Therapeutics Secures $350.7M Series D to Advance Drug Development

Kineticos Unveils Kinvard Bio, a Biotech Focused on Drug-Resistant Infections

atai Life Sciences Acquires Psilera’s DMT Patent Portfolio

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Anthos Therapeutics to Be Acquired by Novartis

AdvanCell Expands Strategic Collaboration with Eli Lilly for Targeted Alpha Therapies

Alterity Therapeutics Secures A$40M to Advance Neurodegenerative Drug Development

Hoth Therapeutics Partners with OnTargetx to Advance Cancer Therapy HT-KIT

Alumis and ACELYRIN Join Forces to Drive Late-Stage Immunology Therapies

Immuneering and Regeneron Partner to Evaluate IMM-1-104 in RAS-Mutant Lung Cancer

Belite Bio Secures $15 Million in Direct Offering with Healthcare Investor

Aplagon Secures €7M to Advance Phase 2a Trial for Thrombo-Inflammatory Drug APAC

Akribion Therapeutics Raises €8M to Advance RNA-Guided Cell Depletion Technology

BioNTech Completes Acquisition of Biotheus

AdvanCell Secures $112M Series C to Expand Radionuclide Cancer Therapies

Enduro Genetics Lands €12M Investment to Expand Bioproduction Technology

Vanda and AnaptysBio Finalise Exclusive Licence Agreement for Imsidolimab in Rare Skin Disease

Tensegrity Pharma Secures JPY150 million (USD0.97 Million) in Seed Funding to Advance Cachexia Drug

Valneva SE Signs $32.8 Million Deal to Supply IXIARO to U.S. Military

European CDMO Landscape 2025: Download the latest edition